{"id":"https://openalex.org/W4322767176","doi":"https://doi.org/10.1016/j.xcrm.2023.100961","title":"A bispecific T cell engager recruits both type 1 NKT and V\u03b39V\u03b42-T cells for the treatment of CD1d-expressing hematological malignancies","display_name":"A bispecific T cell engager recruits both type 1 NKT and V\u03b39V\u03b42-T cells for the treatment of CD1d-expressing hematological malignancies","publication_year":2023,"publication_date":"2023-03-01","ids":{"openalex":"https://openalex.org/W4322767176","doi":"https://doi.org/10.1016/j.xcrm.2023.100961","pmid":"https://pubmed.ncbi.nlm.nih.gov/36868236","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10040383"},"language":"en","primary_location":{"id":"doi:10.1016/j.xcrm.2023.100961","doi":"https://doi.org/10.1016/j.xcrm.2023.100961","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.xcrm.2023.100961","pdf_url":"http://www.cell.com/article/S2666379123000538/pdf","source":{"id":"https://openalex.org/S4210207453","display_name":"Cell Reports Medicine","issn_l":"2666-3791","issn":["2666-3791"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell Reports Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://www.cell.com/article/S2666379123000538/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010947873","display_name":"Roeland Lameris","orcid":"https://orcid.org/0000-0003-4729-8863","observed_orcids":["https://orcid.org/0000-0003-4729-8863"]},"institutions":[{"id":"https://openalex.org/I4210151833","display_name":"Amsterdam University Medical Centers","ror":"https://ror.org/05grdyy37","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I4387152927","display_name":"Cancer Center Amsterdam","ror":"https://ror.org/0286p1c86","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4387152927"]},{"id":"https://openalex.org/I865915315","display_name":"Vrije Universiteit Amsterdam","ror":"https://ror.org/008xxew50","country_code":"NL","type":"education","lineage":["https://openalex.org/I865915315"]},{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Roeland Lameris","raw_affiliation_strings":["Amsterdam UMC location Vrije University Amsterdam, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, the Netherlands"],"raw_orcid":"https://orcid.org/0000-0003-4729-8863","affiliations":[{"raw_affiliation_string":"Amsterdam UMC location Vrije University Amsterdam, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I4210151833","https://openalex.org/I4387152927","https://openalex.org/I865915315","https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066436589","display_name":"Jurjen M. Ruben","orcid":"https://orcid.org/0000-0002-0322-0805","observed_orcids":["https://orcid.org/0000-0002-0322-0805"]},"institutions":[{"id":"https://openalex.org/I4210146011","display_name":"Lava Therapeutics (Netherlands)","ror":"https://ror.org/051k25d02","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210146011"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Jurjen M. Ruben","raw_affiliation_strings":["LAVA Therapeutics, Utrecht, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LAVA Therapeutics, Utrecht, the Netherlands","institution_ids":["https://openalex.org/I4210146011"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014369579","display_name":"Victoria Iglesias\u2010Guimarais","orcid":"https://orcid.org/0009-0009-4116-884X","observed_orcids":["https://orcid.org/0009-0009-4116-884X"]},"institutions":[{"id":"https://openalex.org/I4210146011","display_name":"Lava Therapeutics (Netherlands)","ror":"https://ror.org/051k25d02","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210146011"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Victoria Iglesias-Guimarais","raw_affiliation_strings":["LAVA Therapeutics, Utrecht, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LAVA Therapeutics, Utrecht, the Netherlands","institution_ids":["https://openalex.org/I4210146011"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012998202","display_name":"Milon de Jong","orcid":"https://orcid.org/0000-0001-6121-4211","observed_orcids":["https://orcid.org/0000-0001-6121-4211"]},"institutions":[{"id":"https://openalex.org/I4210151833","display_name":"Amsterdam University Medical Centers","ror":"https://ror.org/05grdyy37","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I4387152927","display_name":"Cancer Center Amsterdam","ror":"https://ror.org/0286p1c86","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4387152927"]},{"id":"https://openalex.org/I865915315","display_name":"Vrije Universiteit Amsterdam","ror":"https://ror.org/008xxew50","country_code":"NL","type":"education","lineage":["https://openalex.org/I865915315"]},{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Milon de Jong","raw_affiliation_strings":["Amsterdam UMC location Vrije University Amsterdam, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amsterdam UMC location Vrije University Amsterdam, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I4210151833","https://openalex.org/I4387152927","https://openalex.org/I865915315","https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042460694","display_name":"Myrthe Veth","orcid":"https://orcid.org/0009-0006-3551-2243","observed_orcids":["https://orcid.org/0009-0006-3551-2243"]},"institutions":[{"id":"https://openalex.org/I4210151833","display_name":"Amsterdam University Medical Centers","ror":"https://ror.org/05grdyy37","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I4387152927","display_name":"Cancer Center Amsterdam","ror":"https://ror.org/0286p1c86","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4387152927"]},{"id":"https://openalex.org/I865915315","display_name":"Vrije Universiteit Amsterdam","ror":"https://ror.org/008xxew50","country_code":"NL","type":"education","lineage":["https://openalex.org/I865915315"]},{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Myrthe Veth","raw_affiliation_strings":["Amsterdam UMC location Vrije University Amsterdam, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amsterdam UMC location Vrije University Amsterdam, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I4210151833","https://openalex.org/I4387152927","https://openalex.org/I865915315","https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039725151","display_name":"Fleur S. van de Bovenkamp","orcid":"https://orcid.org/0000-0003-0507-268X","observed_orcids":["https://orcid.org/0000-0003-0507-268X"]},"institutions":[{"id":"https://openalex.org/I4210146011","display_name":"Lava Therapeutics (Netherlands)","ror":"https://ror.org/051k25d02","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210146011"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Fleur S. van de Bovenkamp","raw_affiliation_strings":["LAVA Therapeutics, Utrecht, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LAVA Therapeutics, Utrecht, the Netherlands","institution_ids":["https://openalex.org/I4210146011"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010497761","display_name":"Iris de Weerdt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I4387152927","display_name":"Cancer Center Amsterdam","ror":"https://ror.org/0286p1c86","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4387152927"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Iris de Weerdt","raw_affiliation_strings":["Amsterdam UMC location University of Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amsterdam UMC location University of Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I2802928900","https://openalex.org/I4387152927"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064164625","display_name":"Arnon Philip Kater","orcid":"https://orcid.org/0000-0003-3190-1891","observed_orcids":["https://orcid.org/0000-0003-3190-1891"]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I4387152927","display_name":"Cancer Center Amsterdam","ror":"https://ror.org/0286p1c86","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4387152927"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Arnon P. Kater","raw_affiliation_strings":["Amsterdam UMC location University of Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amsterdam UMC location University of Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I2802928900","https://openalex.org/I4387152927"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083385949","display_name":"Sonja Zweegman","orcid":"https://orcid.org/0000-0002-5011-1820","observed_orcids":["https://orcid.org/0000-0002-5011-1820"]},"institutions":[{"id":"https://openalex.org/I4210151833","display_name":"Amsterdam University Medical Centers","ror":"https://ror.org/05grdyy37","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I4387152927","display_name":"Cancer Center Amsterdam","ror":"https://ror.org/0286p1c86","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4387152927"]},{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Sonja Zweegman","raw_affiliation_strings":["Amsterdam UMC location Vrije University Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amsterdam UMC location Vrije University Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I4210151833","https://openalex.org/I4387152927","https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070659057","display_name":"Sjeng Horbach","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sjeng Horbach","raw_affiliation_strings":["J&S Preclinical Solutions, Oss, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"J&S Preclinical Solutions, Oss, the Netherlands","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080461837","display_name":"Thilo Riedl","orcid":"https://orcid.org/0000-0002-7671-3280","observed_orcids":["https://orcid.org/0000-0002-7671-3280"]},"institutions":[{"id":"https://openalex.org/I4210146011","display_name":"Lava Therapeutics (Netherlands)","ror":"https://ror.org/051k25d02","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210146011"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Thilo Riedl","raw_affiliation_strings":["LAVA Therapeutics, Utrecht, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LAVA Therapeutics, Utrecht, the Netherlands","institution_ids":["https://openalex.org/I4210146011"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061303688","display_name":"Benjamin Winograd","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146011","display_name":"Lava Therapeutics (Netherlands)","ror":"https://ror.org/051k25d02","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210146011"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Benjamin Winograd","raw_affiliation_strings":["LAVA Therapeutics, Utrecht, the Netherlands; LAVA Therapeutics, Philadelphia, PA, USA","LAVA Therapeutics, Philadelphia, PA, USA","LAVA Therapeutics, Utrecht, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LAVA Therapeutics, Utrecht, the Netherlands; LAVA Therapeutics, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I4210146011"]},{"raw_affiliation_string":"LAVA Therapeutics, Philadelphia, PA, USA","institution_ids":[]},{"raw_affiliation_string":"LAVA Therapeutics, Utrecht, the Netherlands","institution_ids":["https://openalex.org/I4210146011"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030757583","display_name":"Rob C. Roovers","orcid":"https://orcid.org/0000-0002-9715-2136","observed_orcids":["https://orcid.org/0000-0002-9715-2136"]},"institutions":[{"id":"https://openalex.org/I4210146011","display_name":"Lava Therapeutics (Netherlands)","ror":"https://ror.org/051k25d02","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210146011"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Rob C. Roovers","raw_affiliation_strings":["LAVA Therapeutics, Utrecht, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LAVA Therapeutics, Utrecht, the Netherlands","institution_ids":["https://openalex.org/I4210146011"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032085791","display_name":"Anton E.P. Adang","orcid":"https://orcid.org/0000-0002-9352-8722","observed_orcids":["https://orcid.org/0000-0002-9352-8722"]},"institutions":[{"id":"https://openalex.org/I4210146011","display_name":"Lava Therapeutics (Netherlands)","ror":"https://ror.org/051k25d02","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210146011"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Anton E.P. Adang","raw_affiliation_strings":["LAVA Therapeutics, Utrecht, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LAVA Therapeutics, Utrecht, the Netherlands","institution_ids":["https://openalex.org/I4210146011"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053105927","display_name":"Tanja D. de Gruijl","orcid":"https://orcid.org/0000-0003-1464-8978","observed_orcids":["https://orcid.org/0000-0003-1464-8978"]},"institutions":[{"id":"https://openalex.org/I4210151833","display_name":"Amsterdam University Medical Centers","ror":"https://ror.org/05grdyy37","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I4387152927","display_name":"Cancer Center Amsterdam","ror":"https://ror.org/0286p1c86","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4387152927"]},{"id":"https://openalex.org/I865915315","display_name":"Vrije Universiteit Amsterdam","ror":"https://ror.org/008xxew50","country_code":"NL","type":"education","lineage":["https://openalex.org/I865915315"]},{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Tanja D. de Gruijl","raw_affiliation_strings":["Amsterdam UMC location Vrije University Amsterdam, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amsterdam UMC location Vrije University Amsterdam, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I4210151833","https://openalex.org/I4387152927","https://openalex.org/I865915315","https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039190287","display_name":"Paul W.H.I. Parren","orcid":"https://orcid.org/0000-0002-4365-3859","observed_orcids":["https://orcid.org/0000-0002-4365-3859"]},"institutions":[{"id":"https://openalex.org/I2800006345","display_name":"Leiden University Medical Center","ror":"https://ror.org/05xvt9f17","country_code":"NL","type":"funder","lineage":["https://openalex.org/I2800006345"]},{"id":"https://openalex.org/I4210146011","display_name":"Lava Therapeutics (Netherlands)","ror":"https://ror.org/051k25d02","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210146011"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Paul W.H.I. Parren","raw_affiliation_strings":["LAVA Therapeutics, Utrecht, the Netherlands; Leiden University Medical Center, Department of Immunology, Leiden, the Netherlands","LAVA Therapeutics, Utrecht, the Netherlands","Leiden University Medical Center, Department of Immunology, Leiden, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LAVA Therapeutics, Utrecht, the Netherlands; Leiden University Medical Center, Department of Immunology, Leiden, the Netherlands","institution_ids":["https://openalex.org/I2800006345","https://openalex.org/I4210146011"]},{"raw_affiliation_string":"LAVA Therapeutics, Utrecht, the Netherlands","institution_ids":["https://openalex.org/I4210146011"]},{"raw_affiliation_string":"Leiden University Medical Center, Department of Immunology, Leiden, the Netherlands","institution_ids":["https://openalex.org/I2800006345"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5039649967","display_name":"Hans J. van der Vliet","orcid":"https://orcid.org/0000-0001-7846-8613","observed_orcids":["https://orcid.org/0000-0001-7846-8613"]},"institutions":[{"id":"https://openalex.org/I4210146011","display_name":"Lava Therapeutics (Netherlands)","ror":"https://ror.org/051k25d02","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210146011"]},{"id":"https://openalex.org/I4210151833","display_name":"Amsterdam University Medical Centers","ror":"https://ror.org/05grdyy37","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I4387152927","display_name":"Cancer Center Amsterdam","ror":"https://ror.org/0286p1c86","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4387152927"]},{"id":"https://openalex.org/I865915315","display_name":"Vrije Universiteit Amsterdam","ror":"https://ror.org/008xxew50","country_code":"NL","type":"education","lineage":["https://openalex.org/I865915315"]},{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Hans J. van der Vliet","raw_affiliation_strings":["Amsterdam UMC location Vrije University Amsterdam, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, the Netherlands; LAVA Therapeutics, Utrecht, the Netherlands. Electronic address: h.vandervliet@lavatherapeutics.com","Amsterdam UMC location Vrije University Amsterdam, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, the Netherlands","LAVA Therapeutics, Utrecht, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amsterdam UMC location Vrije University Amsterdam, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, the Netherlands; LAVA Therapeutics, Utrecht, the Netherlands. Electronic address: h.vandervliet@lavatherapeutics.com","institution_ids":["https://openalex.org/I4210151833","https://openalex.org/I4387152927","https://openalex.org/I865915315","https://openalex.org/I911458345"]},{"raw_affiliation_string":"Amsterdam UMC location Vrije University Amsterdam, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I4210151833","https://openalex.org/I4387152927","https://openalex.org/I865915315","https://openalex.org/I911458345"]},{"raw_affiliation_string":"LAVA Therapeutics, Utrecht, the Netherlands","institution_ids":["https://openalex.org/I4210146011"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5039649967"],"corresponding_institution_ids":["https://openalex.org/I4210146011","https://openalex.org/I4210151833","https://openalex.org/I4387152927","https://openalex.org/I865915315","https://openalex.org/I911458345"],"apc_list":{"value":5460,"currency":"USD","value_usd":5460},"apc_paid":{"value":5460,"currency":"USD","value_usd":5460},"fwci":4.0003,"has_fulltext":true,"cited_by_count":38,"citation_normalized_percentile":{"value":0.95209049,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"4","issue":"3","first_page":"100961","last_page":"100961"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.6470000147819519,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.6470000147819519,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.12540000677108765,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.07150000333786011,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bispecific-t-cell-engagers","display_name":"bispecific T-cell engagers","score":0.9049999713897705},{"id":"https://openalex.org/keywords/vgamma9vdelta2-t-cells","display_name":"V\u03b39V\u03b42 T cells","score":0.9940000176429749},{"id":"https://openalex.org/keywords/cd1d","display_name":"CD1d","score":0.9520000219345093},{"id":"https://openalex.org/keywords/nanobodies","display_name":"nanobodies","score":0.7269999980926514},{"id":"https://openalex.org/keywords/vhh","display_name":"VHH","score":0.8009999990463257},{"id":"https://openalex.org/keywords/trispecific-t-cell-engager","display_name":"trispecific T cell engager","score":0.7609999775886536},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.8820000290870667},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9950000047683716},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.984000027179718},{"id":"https://openalex.org/keywords/t-cell-acute-lymphoblastic-leukemia","display_name":"T-cell acute lymphoblastic leukemia","score":0.9409999847412109},{"id":"https://openalex.org/keywords/on-target-off-tumor-toxicity","display_name":"on-target off-tumor toxicity","score":0.7649999856948853},{"id":"https://openalex.org/keywords/cytokine-release-syndrome","display_name":"cytokine release syndrome","score":0.7540000081062317},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.6679999828338623}],"concepts":[{"id":"https://openalex.org/C2778607024","wikidata":"https://www.wikidata.org/wiki/Q4216825","display_name":"CD1D","level":5,"score":0.6406962275505066},{"id":"https://openalex.org/C139563560","wikidata":"https://www.wikidata.org/wiki/Q224930","display_name":"Natural killer T cell","level":4,"score":0.5031482577323914},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4667990803718567},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.36156922578811646},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.3490303158760071},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.29555821418762207},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.09978696703910828}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D019337","descriptor_name":"Hematologic Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D050378","descriptor_name":"T-Lymphocytes, Regulatory","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":9,"locations":[{"id":"doi:10.1016/j.xcrm.2023.100961","doi":"https://doi.org/10.1016/j.xcrm.2023.100961","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.xcrm.2023.100961","pdf_url":"http://www.cell.com/article/S2666379123000538/pdf","source":{"id":"https://openalex.org/S4210207453","display_name":"Cell Reports Medicine","issn_l":"2666-3791","issn":["2666-3791"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell Reports Medicine","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10040383","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10040383","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10040383/pdf/main.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell Rep Med","raw_type":"Text"},{"id":"pmid:36868236","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36868236","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell reports. Medicine","raw_type":"Journal Article"},{"id":"pmh:oai:pure.atira.dk:openaire/2f87f250-7f79-4b21-bdf9-4dce0e7c7619","doi":null,"is_oa":true,"landing_page_url":"https://research.vumc.nl/en/publications/2f87f250-7f79-4b21-bdf9-4dce0e7c7619","pdf_url":null,"source":{"id":"https://openalex.org/S7407055350","display_name":"Amsterdam UMC (VU Amsterdam) - Institutional Repository","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lameris, R, Ruben, J M, Iglesias-Guimarais, V, de Jong, M, Veth, M, van de Bovenkamp, F S, de Weerdt, I, Kater, A P, Zweegman, S, Horbach, S, Riedl, T, Winograd, B, Roovers, R C, Adang, A E P, de Gruijl, T D, Parren, P W H I & van der Vliet, H J 2023, 'A bispecific T cell engager recruits both type 1 NKT and V\u03b39V\u03b42-T cells for the treatment of CD1d-expressing hematological malignancies', Cell Reports Medicine, vol. 4, no. 3, 100961. https://doi.org/10.1016/j.xcrm.2023.100961","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:alma.31UKB_LEU:9940750224802711","doi":null,"is_oa":true,"landing_page_url":"https://scholarlypublications.universiteitleiden.nl/handle/1887/3720977","pdf_url":"https://scholarlypublications.universiteitleiden.nl/download/1887/3720977/1?col=81522199720002711","source":{"id":"https://openalex.org/S4306400850","display_name":"Leiden Repository (Leiden University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I121797337","host_organization_name":"Leiden University","host_organization_lineage":["https://openalex.org/I121797337"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Cell Reports Medicine, No. 3","raw_type":"http://purl.org/coar/resource_type/c_6501"},{"id":"pmh:oai:scholarlypublications.universiteitleiden.nl:item_3720977","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/1887/3720977","pdf_url":"https://scholarlypublications.universiteitleiden.nl/access/item%3A3720978/view","source":{"id":"https://openalex.org/S4306400850","display_name":"Leiden Repository (Leiden University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I121797337","host_organization_name":"Leiden University","host_organization_lineage":["https://openalex.org/I121797337"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Cell Reports Medicine","raw_type":"Article / Letter to editor"},{"id":"pmh:amcpub:oai:pure.amc.nl:publications/babdce9a-5bc5-464d-a011-aecedede571d","doi":null,"is_oa":true,"landing_page_url":"https://pure.amc.nl/en/publications/a-bispecific-t-cell-engager-recruits-both-type-1-nkt-and-v9v2t-cells-for-the-treatment-of-cd1dexpressing-hematological-malignancies(babdce9a-5bc5-464d-a011-aecedede571d).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Cell Reports Medicine, 4(3):100961. Cell Press","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire/8c34c643-a234-467a-9cf2-4518c7445480","doi":null,"is_oa":true,"landing_page_url":"https://pure.amsterdamumc.nl/files/170528558/A-bispecific-t-cell-engager-recruits-both-type-1-nkt-and-v9v2-t-cells-for-the-treatment-of-cd1d-expressing-hematologic.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:vumc:oai:pure.atira.dk:publications/2f87f250-7f79-4b21-bdf9-4dce0e7c7619","doi":null,"is_oa":true,"landing_page_url":"https://research.vumc.nl/en/publications/2f87f250-7f79-4b21-bdf9-4dce0e7c7619","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Cell Reports Medicine, 4(3):100961. Cell Press","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1016/j.xcrm.2023.100961","doi":"https://doi.org/10.1016/j.xcrm.2023.100961","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.xcrm.2023.100961","pdf_url":"http://www.cell.com/article/S2666379123000538/pdf","source":{"id":"https://openalex.org/S4210207453","display_name":"Cell Reports Medicine","issn_l":"2666-3791","issn":["2666-3791"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell Reports Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G6323360581","display_name":null,"funder_award_id":"140343","funder_id":"https://openalex.org/F4320312952","funder_display_name":"Worldwide Cancer Research"}],"funders":[{"id":"https://openalex.org/F4320312952","display_name":"Worldwide Cancer Research","ror":"https://ror.org/031tfbz57"},{"id":"https://openalex.org/F4320321014","display_name":"Vrije Universiteit Amsterdam","ror":"https://ror.org/008xxew50"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4322767176.pdf","grobid_xml":"https://content.openalex.org/works/W4322767176.grobid-xml"},"referenced_works_count":61,"referenced_works":["https://openalex.org/W643010292","https://openalex.org/W1107917109","https://openalex.org/W1505219365","https://openalex.org/W1809672664","https://openalex.org/W1975682198","https://openalex.org/W1985534966","https://openalex.org/W1987983325","https://openalex.org/W1996953593","https://openalex.org/W2028946248","https://openalex.org/W2036186137","https://openalex.org/W2039075914","https://openalex.org/W2040154148","https://openalex.org/W2053319140","https://openalex.org/W2061699947","https://openalex.org/W2063096720","https://openalex.org/W2063909696","https://openalex.org/W2069102137","https://openalex.org/W2073403586","https://openalex.org/W2084322562","https://openalex.org/W2089664117","https://openalex.org/W2103909776","https://openalex.org/W2125994015","https://openalex.org/W2147416109","https://openalex.org/W2152488336","https://openalex.org/W2169610187","https://openalex.org/W2183420221","https://openalex.org/W2223191381","https://openalex.org/W2417893160","https://openalex.org/W2422818173","https://openalex.org/W2471121108","https://openalex.org/W2578029714","https://openalex.org/W2582784681","https://openalex.org/W2586932252","https://openalex.org/W2615844508","https://openalex.org/W2754901959","https://openalex.org/W2759239761","https://openalex.org/W2791034815","https://openalex.org/W2808166290","https://openalex.org/W2883190832","https://openalex.org/W2910737538","https://openalex.org/W2948141873","https://openalex.org/W2971477701","https://openalex.org/W2981760099","https://openalex.org/W2988328495","https://openalex.org/W2998735059","https://openalex.org/W3014980845","https://openalex.org/W3022688237","https://openalex.org/W3031978197","https://openalex.org/W3086013181","https://openalex.org/W3091715320","https://openalex.org/W3105835028","https://openalex.org/W3117196393","https://openalex.org/W3119089372","https://openalex.org/W3121917550","https://openalex.org/W3126594832","https://openalex.org/W3134466246","https://openalex.org/W3135330625","https://openalex.org/W3155973955","https://openalex.org/W3184786317","https://openalex.org/W3193639601","https://openalex.org/W3200574709"],"related_works":["https://openalex.org/W7223097608","https://openalex.org/W3213995839","https://openalex.org/W7223308717","https://openalex.org/W4392784113","https://openalex.org/W3177997717","https://openalex.org/W7166504451","https://openalex.org/W7084895929","https://openalex.org/W4409631628","https://openalex.org/W7154611931","https://openalex.org/W4308384285"],"abstract_inverted_index":{"Bispecific":[0],"T":[1,32],"cell":[2,41,96,100,162],"engagers":[3,42],"(bsTCEs)":[4],"hold":[5],"great":[6],"promise":[7],"for":[8],"cancer":[9],"treatment":[10],"but":[11,79],"face":[12],"challenges":[13,46],"due":[14],"to":[15,62,85],"the":[16,27,112,124],"induction":[17],"of":[18,29,39,114,153],"cytokine":[19,93],"release":[20],"syndrome":[21],"(CRS),":[22],"on-target":[23],"off-tumor":[24],"toxicity,":[25],"and":[26,89,98,119,122,130,140,148,164],"engagement":[28,163],"immunosuppressive":[30],"regulatory":[31],"cells":[33,78,84,121,139],"that":[34,107,123],"limit":[35],"efficacy.":[36],"The":[37],"development":[38],"V\u03b39V\u03b42-T":[40,77,131,161],"may":[43],"overcome":[44],"these":[45,136,169],"by":[47,111],"combining":[48],"high":[49],"therapeutic":[50],"efficacy":[51],"with":[52,70,184],"limited":[53],"toxicity.":[54],"By":[55],"linking":[56],"a":[57,63,68,154,178],"CD1d-specific":[58],"single-domain":[59],"antibody":[60],"(VHH)":[61],"V\u03b42-TCR-specific":[64],"VHH,":[65],"we":[66],"create":[67],"bsTCE":[69,125,157,172],"trispecific":[71],"properties,":[72],"which":[73],"engages":[74],"not":[75],"only":[76],"also":[80],"type":[81,127],"1":[82,128],"NKT":[83,129],"CD1d":[86,108],"+":[87],"tumors":[88],"triggers":[90,126],"robust":[91],"proinflammatory":[92],"production,":[94],"effector":[95],"expansion,":[97],"target":[99],"lysis":[101],"in":[102,143,144,158,177,182],"vitro":[103],".":[104],"We":[105],"show":[106],"is":[109,174],"expressed":[110],"majority":[113],"patient":[115,137],"MM,":[116,147,188],"(myelo)monocytic":[117],"AML,":[118,146],"CLL":[120],"cell-mediated":[132],"antitumor":[133],"activity":[134],"against":[135],"tumor":[138],"improves":[141],"survival":[142],"vivo":[145],"T-ALL":[149],"mouse":[150],"models.":[151],"Evaluation":[152],"surrogate":[155],"CD1d-\u03b3\u03b4":[156],"NHPs":[159],"shows":[160],"excellent":[165],"tolerability.":[166],"Based":[167],"on":[168],"results,":[170],"CD1d-V\u03b42":[171],"(LAVA-051)":[173],"now":[175],"evaluated":[176],"phase":[179],"1/2a":[180],"study":[181],"patients":[183],"therapy":[185],"refractory":[186],"CLL,":[187],"or":[189],"AML.":[190]},"counts_by_year":[{"year":2026,"cited_by_count":13},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":12},{"year":2023,"cited_by_count":7}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-03-03T00:00:00"}